Zepto Life Technology Wins Top Prize in the RESI Boston 2019 Innovation Challenge

September 12, 2019 at 9:00 AM EDT

Zepto, an in-vitro diagnostics company, features uniquely-accurate and multiplex-ready “lab-on-a-chip” technology – co-developed with the Mayo Clinic – to improve patient outcomes through superior assay performance at patients’ exact points of need (a $12B market).

zepto-certificate
How can we help you?

Send us a message.